Cempra Inc (NASDAQ:CEMP)
| 24.86 BATS BZX Real-Time Price As of 11:18am ET |  -1.36 / -5.19%Today’s Change | 14.03 Today|||52-Week Range 34.79 | -20.14% Year-to-Date |
Latest CEMP News | Press Releases
No recent news for Cempra Inc.
Today’s Trading
| Previous close | 26.22 |
| Today’s open | 26.50 |
| Day’s range | 24.75 - 26.50 |
| Volume | 15,983 |
| Average volume (3 months) | 781,619 |
| Market cap | $1.4B |
| Dividend yield | -- |
Data as of 11:18am ET, 09/29/2016
Growth & Valuation
| Earnings growth (last year) | -15.47% |
| Earnings growth (this year) | -26.05% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +79.47% |
| P/E ratio | NM |
| Price/Sales | 49.66 |
| Price/Book | 9.80 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AXONAxovant Sciences Ltd | -0.04 | -0.28% |
| TXMDTherapeuticsMD Inc | -0.05 | -0.74% |
| CLVSClovis Oncology Inc | -1.53 | -4.21% |
| PCRXPacira Pharmaceutica... | -0.80 | -2.25% |
Data as of 11:19am ET, 09/29/2016
Financials
| Next reporting date | October 26, 2016 |
| EPS forecast (this quarter) | -$0.62 |
| Annual revenue (last year) | $27.3M |
| Annual profit (last year) | -$91.1M |
| Net profit margin | -333.64% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Prabhavathi B. Fernandes |
Chief Financial Officer & Executive Vice President Mark W. Hahn |
Corporate headquarters Chapel Hill, North Carolina |
Forecasts
